During the past decade, Saint Luke's East - Lee's Summit conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 105 clinical trials were completed, i.e. on average, 190.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 55 clinical trials were completed. i.e. 550% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Luke's East - Lee's Summit" #1 sponsor was "National Cancer Institute (NCI)" with 72 trials, followed by "SWOG Cancer Research Network" with 44 trials sponsored, "Alliance for Clinical Trials in Oncology" with 32 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Luke's East - Lee's Summit" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Canadian Cancer Trials Group" with 6 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Saint Luke's East - Lee's Summit" are "Breast Cancer" (13 trials), "Colorectal Cancer" (9 trials), "Lung Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "Saint Luke's East - Lee's Summit" in a lesser frequency.

Most popular intervention types in "Saint Luke's East - Lee's Summit" are "Drug" (138 trials), "Other" (111 trials), "Biological" (63 trials), "Procedure" (33 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (36 trials), "Paclitaxel" (20 trials), "Carboplatin" (17 trials) and "Questionnaire Administration" (17 trials). Other intervention names were less common.

The vast majority of trials in "Saint Luke's East - Lee's Summit" are 140 trials for "All" genders, 37 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Luke's East - Lee's Summit". undefined are not yet recruiting, 13 are recruiting, 79 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 71 completed trials in Saint Luke's East - Lee's Summit, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Luke's East - Lee's Summit, 7 "Phase 1" clinical trials were conducted, 76 "Phase 2" clinical trials and 86 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".